ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0054

MDSCs in Inflammatory Joints of SKG Mice Suppress T Cells and Differentiate into Osteoclasts

Yoshikazu Fujikawa1, Sho Sendo2, Takumi Nagamoto3, Yuzuru Yamamoto1, Takaichi Okano4, Keisuke Nishimura3, Yo Ueda5 and Jun Saegusa5, 1Hyogo Prefectural Harima-Himeji General Medical Center, Himeji, Japan, 2University California, San Diego (UCSD), La Jolla, CA, 3Kobe University, Kobe, Japan, 4Kobe University Hospital, Kobe, Japan, 5Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan

Meeting: ACR Convergence 2022

Keywords: Inflammation, Mouse Models, RA, osteoclastogenesis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: RA – Animal Models Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Myeloid-derived suppressor cells (MDSCs) are heterogeneous immature myeloid cells with suppressive functions. It is known that MDSCs are expanded in inflammatory sites after migrating from bone marrow (BM) or spleen. Rheumatoid arthritis (RA) is an autoimmune disease characterized as polyarthritis. Although previous reports indicate that MDSCs are increased in BM and spleen of arthritis model mice, detailed analysis of MDSCs in inflammatory joints is very limited.
The purpose of this study is to characterize the MDSCs in the joints of autoimmune arthritis.

Methods: We isolated CD11b+Gr1+ cells as MDSCs from joints (Jo-MDSCs), bone marrow (BM-MDSCs) and spleen (Sp-MDSCs) of arthritis-induced SKG mice, and investigated differential expressed genes (DEGs) among MDSCs from three tissues by microarray analysis. Based on the results, we analyzed the suppressive function and the osteoclast differentiation ability of MDSCs from each organ.

Results: We detected CD11b+Gr1+ cells as MDSCs in joints of SKG arthritic mice by flowcytometric analysis and morphological inspection. Microarray analysis revealed that Jo-MDSCs had differential characteristics compared with BM-MDSCs or Sp-MDSCs. Microarray and qPCR analysis showed that Jo-MDSCs highly expressed immunosuppressive DEGs (Pdl1, Arg1, Egr2 and Egr3). In vitro, Jo-MDSCs suppressed CD4+ T cell proliferation with significance compared to control (% proliferated cells: 44±4 % and 70±3 % for Jo-MDSCs and control, respectively; p< 0.01). Microarray analysis also revealed that Jo-MDCSs highly expressed NF-κB non-canonical pathway DEGs (Nfkb2 and Relb), which is relevant to osteoclast differentiation. In vitro, Jo-MDSCs differentiated into osteoclasts but not Sp-MDSCs (Count of multiple nuclei cells/well: 94±14 and 11±3 for Jo-MDSCs and Sp-MDSCs, respectively; p< 0.01).

Conclusion: Jo-MDSCs are immunosuppressive while potentially differentiate into osteoclasts.

Supporting image 1

Figure1 Detection of BM-, Spleen- and Joint-MDSC from autoimmune arthritis-induced SKG mice. Representative flow cytometry plots of total MDSCs (CD11b+Gr1+ cells) (upper), May-Giemsa staining of CD11b+Gr1+ cells (MDSC) isolated from BM, spleen and joints of arthritic SKG mice (lower).

Supporting image 2

Figure2 Jo-MDSCs have an osteoclast differentiation potential. A, Representative images of TRAP staining which are differentiated from BM-/Sp-/Jo-MDSCs stimulated by M-CSF and RANKL for 10 days (n=7 each). B, Cell counts of multi-nucleated cells (MNCs)/well in each group. Data are shown as mean ± SEM. ***P <0.001, ** P<0.01, by one-way analysis of variance and Tukey’s multiple comparison test.


Disclosures: Y. Fujikawa, None; S. Sendo, None; T. Nagamoto, None; Y. Yamamoto, None; T. Okano, None; K. Nishimura, None; Y. Ueda, None; J. Saegusa, None.

To cite this abstract in AMA style:

Fujikawa Y, Sendo S, Nagamoto T, Yamamoto Y, Okano T, Nishimura K, Ueda Y, Saegusa J. MDSCs in Inflammatory Joints of SKG Mice Suppress T Cells and Differentiate into Osteoclasts [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/mdscs-in-inflammatory-joints-of-skg-mice-suppress-t-cells-and-differentiate-into-osteoclasts/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mdscs-in-inflammatory-joints-of-skg-mice-suppress-t-cells-and-differentiate-into-osteoclasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology